Research for more sustainable crop production: A new type of research greenhouse is now being built at the University of Bonn's Klein-Altendorf campus. The German Federal Ministry of Education and Research (BMBF) is providing 8.1 million euros in funding for the project, called START. Partners from various institutions will be working together here on an interdisciplinary basis over the next four years. Construction of the deep water culture greenhouse at the Klein-Altendorf campus is scheduled to begin this year so that demonstration operations can begin in 2024.
To mark World Day for Laboratory Animals, the Faculty of Agriculture at the University of Bonn ran a fact-finding event on animal testing for its students.
What possibilities does mRNA technology offer? How can we use computers to answer biomedical questions? And how does what I eat affect my immune system? The ImmunoSensation2 Cluster of Excellence at the University of Bonn will be celebrating the International Day of Immunology in Bonn’s city center on April 29. On Marktplatz, researchers will be providing a personal insight into their work and will be on hand from 10 am to 6 pm to chat with locals and answer their questions. At Bonn City Library, meanwhile, selected topics from the field of biomedicine will be showcased in more detail between 11 am and 2 pm. Admission is free at both venues.
On the occasion of World Day for Laboratory Animals, researchers of the 3R Competence Network NRW explain how animal experimentation can be improved and why it is still necessary.
Mathematical modelling and analysis are essential for all fields of the life sciences nowadays, ranging from basic research to clinical application. The collaboration between mathematicians and life scientists has a long tradition in Bonn. This week Bonn researchers exchange views with colleagues from Germany and abroad on the current status and possible future developments at an international conference at the Wissenschaftszentrum Bonn.
Cisplatin is used successfully in the chemotherapy of testicular cancer. However, patients who develop resistance to the cytostatic drug urgently need alternative therapy options. Researchers at the University Hospital Bonn (UKB) have now been able to elucidate a mechanism underlying cisplatin resistance in testicular cancer. Using CRISPR gene scissors, they identified the NAE1 gene as its driver. Inhibiting this resistance mediator by adding the NAE1 inhibitor MLN4924 not only restores the effect of cisplatin, but also has an additional killing effect on tumor cells. The study results have now been published in the British Journal of Cancer.